Found: 15
Select item for more details and to access through your institution.
Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH).
- Published in:
- Pharmacology Research & Perspectives, 2023, v. 11, n. 3, p. 1, doi. 10.1002/prp2.1094
- By:
- Publication type:
- Article
Synthetic lipophilic antioxidant BO-653 suppresses HCV replication.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 2, p. 241, doi. 10.1002/jmv.23466
- By:
- Publication type:
- Article
Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 4, p. 587, doi. 10.1002/jmv.21970
- By:
- Publication type:
- Article
Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142145
- By:
- Publication type:
- Article
Hepatitis C Virus NS3/4A Protease Inhibits Complement Activation by Cleaving Complement Component 4.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082094
- By:
- Publication type:
- Article
Isolation and sequencing of the Candida albicans MSI3, a putative novel member of the HSP70 family.
- Published in:
- Yeast, 2003, v. 20, n. 2, p. 149, doi. 10.1002/yea.952
- By:
- Publication type:
- Article
Monoclonal Antibody 2-152a Suppresses Hepatitis C Virus Infection Through Betaine/ GABA Transporter-1.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 8, p. 1172, doi. 10.1093/infdis/jir501
- By:
- Publication type:
- Article
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
- Published in:
- International Journal of Experimental Pathology, 2013, v. 94, n. 2, p. 93, doi. 10.1111/iep.12008
- By:
- Publication type:
- Article
Self-Enhancement of Hepatitis C Virus Replication by Promotion of Specific Sphingolipid Biosynthesis.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 8, p. 1, doi. 10.1371/journal.ppat.1002860
- By:
- Publication type:
- Article
Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00515-y
- By:
- Publication type:
- Article
In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep04750
- By:
- Publication type:
- Article
Establishment of infectious HCV virion-producing cells with newly designed full-genome replicon RNA.
- Published in:
- Archives of Virology, 2011, v. 156, n. 2, p. 295, doi. 10.1007/s00705-010-0859-x
- By:
- Publication type:
- Article
An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes.
- Published in:
- PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0216139
- By:
- Publication type:
- Article
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
- Published in:
- Nature Chemical Biology, 2005, v. 1, n. 6, p. 333, doi. 10.1038/nchembio742
- By:
- Publication type:
- Article
Characterization of Chitin Synthase 2 of Saccharomyces cerevisiae II: Both Full Size and Processed Enzymes Are Active for Chitin Synthesis.
- Published in:
- Journal of Biochemistry, 1996, v. 119, n. 4, p. 659, doi. 10.1093/oxfordjournals.jbchem.a021293
- By:
- Publication type:
- Article